Mirtazapine Tablet, Film Coated
Product Images NDC 70518-2581

2 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 70518-2581). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Mirtazapine Str)

Chemical Structure (Mirtazapine Str)
Chemical structure of mirtazapine, a human prescription drug active ingredient, showing its molecular ring system and chemical bonds.*
FDA Label Image

Mm1 (Mirtazapine 45mg 70518 2581 00)

Mm1 (Mirtazapine 45mg 70518 2581 00)
Mirtazapine 45 mg tablet label showing quantity of 30 tablets. The label includes the NDC 70518-2581-00, manufacturer information for Rising Pharma, Inc. of Allendale, NJ, and repackager RemedyRepack Inc. in Indiana, PA. Storage instructions range from 20-25°C with excursions permitted between 15-30°C. The label states 'RX ONLY' and directs to see the insert for usual dosage.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.